What is the impact of Helicobacter pylori density on the success of eradication therapy: A clinico-histopathological study

Onal, Ibrahim; Gokcan, Hale; Benzer, Emine; Bilir, Gulay; Oztas, ERKİN

doi:10.1016/j.clinre.2013.05.005

What is the impact of Helicobacter pylori density on the success of eradication therapy: A clinico-histopathological study

Atıf İçin Kopyala

Onal I. K., Gokcan H., Benzer E., Bilir G., Oztas E.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, cilt.37, sa.6, ss.642-646, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 37 Sayı: 6
Basım Tarihi: 2013
Doi Numarası: 10.1016/j.clinre.2013.05.005
Dergi Adı: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.642-646
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background and objective: To investigate the presence of any possible association between H. pylori density in the stomach and the efficacy of triple (lansoprazole 30mg b.i.d., clarithromycin 500mg b.i.d. and amoxicillin 1g b.i.d. for 14 days) and bismuth-containing quadruple (colloidal bismuth subcitrate 300mg q.i.d., lansoprazole 30mg b.i.d., tetracycline 500mg q.i.d. and metronidazole 500mg t.i.d. for 14 days) eradication therapies.